HLA-C*070201 & B2M Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| DR-01 | DR-01 | Phase 2 Clinical | Dren Bio Inc | Leukemia; Enteropathy-Associated T-Cell Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma; Lymphoma, T-Cell; Bacterial Infections; Autoimmune Diseases of the Nervous System; Leukemia, Large Granular Lymphocytic | Details |